Research Article
Nuclear p27 Expression Confers a Favorable Outcome for Nasopharyngeal Carcinoma Patients
Table 2
Summary of univariate and multivariate Cox regression analysis of overall survival duration.
| Parameter | Univariate analysis | Multivariate analysis | | HR | 95% CI | | HR | 95% CI |
| Gender | | | | | | | Male versus female | 0.485 | 0.488 | 0.665–2.361 | | | | Age | | | | | | | ≥50 versus 50 years | 0.787 | 0.073 | 0.620–1.881 | | | | Family tumor history | | | | | | | Yes versus no | 0.349 | 0.877 | 0.000–28.401 | | | | Smoking | | | | | | | Yes versus no | 0.387 | 0748 | 0.368–1.474 | | | | Chemotherapy | | | | | | | Yes versus no | 0.700 | 1.153 | 0.560–2.372 | | | | Radiotherapy | | | | | | | Yes versus no | 0.005 | 0.369 | 0.184–0.742 | 0.990 | 0.994 | 0.419–2.358 | T classification | | | | | | | T1-T2 versus T3-T4 | 0.000 | 28.042 | 2.674–8.496 | 0.014 | 2.725 | 1.222–6.075 | N classification | | | | | | | N0-N1 versus N2-N3 | 0.000 | 2.950 |
1.662–5.237 | 0.240 | 1.633 | 0.720–3.702 | M classification | | | | | | | M0 versus M1 | 0.000 | 35.042 | 5.031–24.906 | 0.005 | 4.461 | 1576–12.633 | TNM clinical stage | | | | | | | I-II versus III-IV | 0.000 | 19.386 | 3.592–27.943 | 0.051 | 3.758 | 0.992–14.239 | p27 nuclear expression | | | | | | | Positive expression versus negative expression | 0.009 | 0.460 | 0.257–0.822 | 0.690 | 0.878 | 0.464–1.661 |
|
|